Lycia Therapeutics
Other · United States
About Lycia Therapeutics
Lycia is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting chimera) protein degraders that harness the cell’s lysosomal trafficking and degradation pathway to target both soluble and membrane-bound extracellular proteins. Applications of the LYTAC platform include: targeting challenging membrane proteins, clearing pathogenic immune...
Facts
- Industry
- Other
- Company size
- Startup · ~39 employees
- Headquarters
- United States
- Website
- https://lyciatx.com/
Hiring activity
4 open roles right now · 1 added in the last 30 days
Most recent posting: July 1, 2026
Roles they hire for:
- Senior Director, Controller
- Executive Assistant
- Vice President, Head, Nonclinical Development
- Vice President (VP) / Senior VP, Clinical Development
Similar companies
- BAYADA Home Health Care
- Advocate Aurora Health
- Trinity Health (HQ Michigan)
- Cinemark
- Alten Mexico
- CyberArk
See which of these 4 roles match your resume
Sign up free